A D Habberfield

898 total citations
20 papers, 778 citations indexed

About

A D Habberfield is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, A D Habberfield has authored 20 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in A D Habberfield's work include Neuropeptides and Animal Physiology (5 papers), Metabolism, Diabetes, and Cancer (4 papers) and Adipose Tissue and Metabolism (3 papers). A D Habberfield is often cited by papers focused on Neuropeptides and Animal Physiology (5 papers), Metabolism, Diabetes, and Cancer (4 papers) and Adipose Tissue and Metabolism (3 papers). A D Habberfield collaborates with scholars based in United Kingdom, United States and Mexico. A D Habberfield's co-authors include Ian A. Simpson, C. J. Dix, John Saltis, Samuel W. Cushman, I J Kozka, Geoffrey D. Holman, A E Clark, B.A. Cooke, M.H.F. Sullivan and Steven Westwood and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemical Journal.

In The Last Decade

A D Habberfield

20 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A D Habberfield United Kingdom	12	508	181	177	116	111	20	778
David L. DiPietro United States	13	398 0.8×	206 1.1×	161 0.9×	99 0.9×	262 2.4×	19	803
R Sikstrom Canada	11	507 1.0×	238 1.3×	131 0.7×	191 1.6×	221 2.0×	17	803
E. A. Bergner United States	12	422 0.8×	97 0.5×	180 1.0×	52 0.4×	70 0.6×	16	750
Howard M. Katzen United States	16	610 1.2×	278 1.5×	217 1.2×	151 1.3×	87 0.8×	21	954
Holly D. Cox United States	18	301 0.6×	132 0.7×	54 0.3×	115 1.0×	241 2.2×	37	840
Gerardo M. Castillo United States	15	515 1.0×	127 0.7×	385 2.2×	293 2.5×	23 0.2×	45	1.2k
B S Tsai United States	19	565 1.1×	96 0.5×	377 2.1×	25 0.2×	85 0.8×	37	1.1k
Norbert I. Swislocki United States	15	328 0.6×	99 0.5×	182 1.0×	56 0.5×	68 0.6×	44	625
Yvonne Denkins United States	15	297 0.6×	52 0.3×	199 1.1×	111 1.0×	121 1.1×	16	857
Hitoshi Akedo Japan	13	423 0.8×	46 0.3×	104 0.6×	126 1.1×	28 0.3×	26	749

Countries citing papers authored by A D Habberfield

Since Specialization

Citations

This map shows the geographic impact of A D Habberfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A D Habberfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A D Habberfield more than expected).

Fields of papers citing papers by A D Habberfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A D Habberfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A D Habberfield. The network helps show where A D Habberfield may publish in the future.

Co-authorship network of co-authors of A D Habberfield

This figure shows the co-authorship network connecting the top 25 collaborators of A D Habberfield. A scholar is included among the top collaborators of A D Habberfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A D Habberfield. A D Habberfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Whitcomb, K. Lane, et al.. (1996). Enteral Bioavailability of Human Granulocyte Colony Stimulating Factor Conjugated with Poly(ethylene glycol). Pharmaceutical Research. 13(1). 102–107. 23 indexed citations

Habberfield, A D. (1996). Vitamin B12-mediated uptake of erythropoietin and granulocyte colony stimulating factor in vitro and in vivo. International Journal of Pharmaceutics. 145(1-2). 1–8. 29 indexed citations

Russell‐Jones, Gregory, Steven Westwood, & A D Habberfield. (1995). Vitamin B12 Mediated Oral Delivery Systems for Granulocyte-Colony Stimulating Factor and Erythropoietin. Bioconjugate Chemistry. 6(4). 459–465. 62 indexed citations

Niven, Ralph W., et al.. (1994). Pulmonary absorption of polyethylene glycolated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF). Journal of Controlled Release. 32(2). 177–189. 16 indexed citations

Saltis, John, A D Habberfield, John J. Egan, et al.. (1991). Role of protein kinase C in the regulation of glucose transport in the rat adipose cell. Translocation of glucose transporters without stimulation of glucose transport activity.. Journal of Biological Chemistry. 266(1). 261–267. 42 indexed citations

Nishimura, H, John Saltis, A D Habberfield, et al.. (1991). Phosphorylation state of the GLUT4 isoform of the glucose transporter in subfractions of the rat adipose cell: effects of insulin, adenosine, and isoproterenol.. Proceedings of the National Academy of Sciences. 88(24). 11500–11504. 42 indexed citations

Holman, Geoffrey D., I J Kozka, A E Clark, et al.. (1990). Cell surface labeling of glucose transporter isoform GLUT4 by bis-mannose photolabel. Correlation with stimulation of glucose transport in rat adipose cells by insulin and phorbol ester.. Journal of Biological Chemistry. 265(30). 18172–18179. 292 indexed citations

Simpson, Ian A., Samuel W. Cushman, John J. Egan, et al.. (1990). Hormonal regulation of glucose transport in rat adipose cells. Biochemical Society Transactions. 18(6). 1123–1125. 5 indexed citations

Joost, Hans‐Georg, A D Habberfield, Ian A. Simpson, Antonio Laurenza, & Kenneth B. Seamon. (1988). Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action.. Molecular Pharmacology. 33(4). 449–453. 80 indexed citations

10.

Habberfield, A D, C. J. Dix, & B.A. Cooke. (1987). The dynamics of LH-induced desensitization of adenylate cyclase and LH receptor internalization in rat Leydig cells at physiological levels of LH. Journal of Endocrinology. 114(3). 415–422. 13 indexed citations

11.

Dix, C. J., et al.. (1987). Similarities and differences in phorbol ester- and luteinizing-hormone-induced desensitization of rat tumour Leydig-cell adenylate cyclase. Biochemical Journal. 243(2). 373–377. 7 indexed citations

12.

Habberfield, A D, C. J. Dix, & B.A. Cooke. (1987). Effects of lutropin (LH) receptor internalization and recycling on the apparent numbers of LH receptors in rat testis Leydig cells at different temperatures. Molecular and Cellular Endocrinology. 51(1-2). 153–161. 11 indexed citations

13.

Habberfield, A D, et al.. (1986). Evidence for the rapid internalization and recycling of lutropin receptors in rat testis Leydig cells. Biochemical Journal. 233(2). 369–376. 32 indexed citations

14.

Dix, C. J., et al.. (1985). Adenosine potentiates lutropin-stimulated cyclic AMP production and inhibits lutropin-induced desensitization of adenylate cyclase in rat Leydig tumour cells. Biochemical Journal. 230(1). 211–216. 9 indexed citations

15.

Dix, C. J., A D Habberfield, Mark Sullivan, & B.A. Cooke. (1985). Evidence for the involvement of lipoxygenase products in steroidogenesis. Biochemical Society Transactions. 13(1). 60–63. 9 indexed citations

16.

Habberfield, A D, C. J. Dix, & B.A. Cooke. (1985). Lutropin-induced desensitization of adenylate cyclase, internalization and recycling of lutropin receptors in testis Leydig cells. Biochemical Society Transactions. 13(6). 1129–1130. 1 indexed citations

17.

Dix, C. J., et al.. (1984). Characterization of the homologous and heterologous desensitization of rat Leydig-tumour-cell adenylate cyclase. Biochemical Journal. 220(3). 803–809. 13 indexed citations

18.

Dix, C. J., A D Habberfield, M.H.F. Sullivan, & B.A. Cooke. (1984). Inhibition of steroid production in Leydig cells by non-steroidal anti-inflammatory and related compounds: evidence for the involvement of lipoxygenase products in steroidogenesis. Biochemical Journal. 219(2). 529–537. 75 indexed citations

19.

Cooke, B.A., C. J. Dix, A D Habberfield, & M.H.F. Sullivan. (1984). Control of Steroidogenesis in Leydig Cells: Roles of Ca²⁺ and Lipoxygenase Products in LH and LHRH Agonist Action. Annals of the New York Academy of Sciences. 438(1). 269–282. 9 indexed citations

20.

Tisdale, Michael J. & A D Habberfield. (1980). Selective inhibition of ribonucleotide reductase by the monofunctional alkylating agent 5(1-aziridinyl)-2,4-dinitrobenzamide (CB 1954). Biochemical Pharmacology. 29(20). 2845–2853. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact